Flex Pharma Reports Year End 2014 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Flex Pharma Reports Year End 2014 Financial Results

Flex Pharm (FLKS) PT Raised to $27 at Cantor Fitzgerald Ahead of Consumer Product Launch

March 18, 2015 7:23 AM EDT

Cantor Fitzgerald analyst Mara Goldstein reiterated a Buy rating and raised her price target on Flex Pharma (NASDAQ: FLKS) to $27.00 (from $22.00) following Q4 results.

The price target hike reflect the pre-launch for the consumer product for exercise associated muscle cramps... More